Innovation Pharmaceuticals Inc (IPIX)

[baytdr]

This latest update seems likely to have been calculated to encourage potential partners to get serious as they are not alone, as well as to keep us informed about progress on multiple fronts. Taken as a whole UP/UPS, UC, Crohn's Disease and Brilacidin OM represents an extremely valuable platform drug for "global BP". Dr. B is marketing B via these updates as a novel, non-corticosteriod, non-biologic IBD treatment. Each trial supports the efficacy and safety profile of the entire platform and their MOA's. Formulation development plans include foam and/or gel for the treatment of UP/UPS and oral tablets for the treatment of UC and Crohn's. The soon to be released top line for OM should serve to inspire competitive interest for a potentially huge block buster of global scale.